Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 1/20 | 0.68 |
| ▸ | HDAC1 | Q13547 | 4/20 | 0.58 |
| ▸ | HDAC2 | Q92769 | 4/20 | 0.58 |
| ▸ | CA12 | O43570 | 9/20 | 0.55 |
| ▸ | CA9 | Q16790 | 8/20 | 0.55 |
| ▸ | CA1 | P00915 | 1/20 | 0.53 |
| ▸ | CA2 | P00918 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | PTPRC | P08575 | 1/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.42 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30873067 | 1.00 | RAB9A (0.68) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL27183230 | 0.89 | CA12 (0.55) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL7291555 | 0.86 | RAB9A (0.72) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL7299633 | 0.81 | RAB9A (1.00) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL30872997 | 0.81 | ACE2 (0.60) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL25518891 | 0.81 | ACE2 (0.60) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL8668121 | 0.80 | HDAC1 (0.67) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL7280532 | 0.78 | RAB9A (0.69) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL23507209 | 0.78 | RAB9A (0.58) | RAB9AHDAC1HDAC2CA12CA9 | |
| SCHEMBL8891388 | 0.76 | CA12 (0.61) | RAB9AHDAC1HDAC2CA12CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | disclosed |
| EP-4344552-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2024-04-03 | — | — | EP | disclosed |
| CN-102652155-B | Disperse azo dyes, a process for the preparation thereof and the use thereof | HUNSTSMAN ADVANCED MATERIALS SWITZERLAND GMBH | 2014-11-05 | — | — | CN | disclosed |
| EP-2513229-B1 | DISPERSE AZO DYES, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | HUNTSMAN ADV MAT SWITZERLAND (CH) | 2014-04-23 | — | — | EP | disclosed |
| EP-2513229-B1 | DISPERSE AZO DYES, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | HUNTSMAN ADV MAT SWITZERLAND (CH) | 2014-04-23 | — | — | EP | disclosed |
| EP-2513229-A1 | DISPERSE AZO DYES, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | Huntsman Advanced Materials (Switzerland) GmbH (CH) | 2012-10-24 | — | — | EP | disclosed |
| CN-102652155-A | Disperse azo dyes, a process for the preparation thereof and the use thereof | HUNSTSMAN ADVANCED MATERIALS SWITZERLAND GMBH | 2012-08-29 | — | — | CN | disclosed |
| WO-2011072966-A1 | DISPERSE AZO DYES, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | HUNSTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2011-06-23 | — | — | WO | disclosed |
| WO-2011072966-A1 | DISPERSE AZO DYES, A PROCESS FOR THE PREPARATION THEREOF AND THE USE THEREOF | HUNSTSMAN ADVANCED MATERIALS (SWITZERLAND) GMBH (CH) | 2011-06-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | RAB9A 409/4885HDAC1 3142/4885HDAC2 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.